Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
42.45 M
About Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. is a clinical-stage healthcare company, which engages in the provision of healthcare services. It focuses on leveraging the microbiome organ to treat disease and improve human health. The firm offers microbiome metabolic therapies (MMT), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and composition of the organ's existing microbes. The company was founded by Geoffrey von Maltzahn and Noubar B. Afeyan on January 27, 2015 and is headquartered in Lexington, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KLDO is 0.000100 USD — it hasn't changed in the past 24 hours. Watch Kaleido Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Kaleido Biosciences, Inc. stocks are traded under the ticker KLDO.
Kaleido Biosciences, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
KLDO stock is 9.90 K% volatile and has beta coefficient of 379.67. Track Kaleido Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Kaleido Biosciences, Inc. there?
KLDO earnings for the last quarter are −0.54 USD per share, whereas the estimation was −0.54 USD resulting in a 0.31% surprise. The estimated earnings for the next quarter are −0.58 USD per share. See more details about Kaleido Biosciences, Inc. earnings.
Kaleido Biosciences, Inc. revenue for the last quarter amounts to 104.00 K USD despite the estimated figure of 170.00 K USD. In the next quarter revenue is expected to reach 1.12 M USD.
Yes, you can track Kaleido Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
KLDO stock hasn't changed in a week, the last month showed zero change in price, over the last year Kaleido Biosciences, Inc. has showed a 50.00% decrease.
No, KLDO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, KLDO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kaleido Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
KLDO reached its all-time high on Jan 28, 2021 with the price of 20.500000 USD, and its all-time low was 0.000001 USD and was reached on May 9, 2023. View more price dynamics on KLDO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kaleido Biosciences, Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kaleido Biosciences, Inc. stock shows the sell signal. See more of Kaleido Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.